NewGenIvf Prices $1.25M Offering at $0.07 — 79.7% Below Market, Triggering Nasdaq Delisting Risk
NIVF has more than doubled off its 52-week low of $0.064 on elevated volume (39× avg).
Summary
NewGenIvf priced a $1.25M best-efforts offering at $0.07 per share — a 79.7% discount to market — using pre-funded warrants that could expand the share count by over 7x. The company acknowledges Nasdaq may delist the stock over the dilutive terms.
Updates
· SEC 6-K — The offering closed on September 30, 2026, with 125,000 Class A shares and pre-funded warrants for 17,732,143 shares issued for $1.25M gross proceeds.
Key Events · Financing and Capital Events · NIVF
-
Deeply Discounted Offering Priced
125,000 Class A shares at $0.07 each plus 17,732,143 pre-funded warrants at $0.06999, totaling $1.25M gross proceeds — a 79.7% discount to the $0.3448 last sale price on September 28, 2026.
-
Massive Potential Dilution
If all pre-funded warrants are exercised, outstanding Class A shares rise from 2,776,980 to 20,634,123 — a 7.4x increase. The warrant structure bypasses the 4.99% beneficial ownership cap.
-
Nasdaq Delisting Risk
The company discloses Nasdaq may halt trading or delist the stock for public interest concerns due to the highly dilutive, deeply discounted offering. The $0.07 price is below Nasdaq's $1.00 minimum bid requirement.
-
Use of Proceeds
Net proceeds of approximately $1.05M will fund K25.ai investment, debt restructuring, Nodexus machine deployment, and working capital.
Analysis · NIVF · Industrial Applications And Services
NewGenIvf finalized a deeply discounted offering at $0.07 per share, a 79.7% discount to the $0.3448 last sale price on September 28, 2026. The structure uses 17.7 million pre-funded warrants to bypass the 4.99% beneficial ownership cap, meaning the effective share count could expand from 2.78 million to over 20.6 million Class A shares if all warrants are exercised — a roughly 7.4x increase. The company itself warns Nasdaq may halt trading or delist the stock for public interest concerns due to the highly dilutive nature of this offering. This comes after eight reverse stock splits in 18 months and a going-concern warning, with the company needing capital to fund K25.ai investments and debt restructuring. The offering price is below Nasdaq's $1.00 minimum bid price, and the company has already exhausted its compliance grace periods under Nasdaq rules.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 41.9% of the 327 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.46%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NIVF was trading at $0.15 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $162.4K. The 52-week trading range was $0.06 to $1,539.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.